Clover Health Investments Net Profit Margin 2020-2024 | CLOV

Clover Health Investments net profit margin from 2020 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
Clover Health Investments Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2024-12-31 $1.37B $-0.04B -3.14%
2024-09-30 $1.35B $-0.09B -6.76%
2024-06-30 $1.32B $-0.12B -9.31%
2024-03-31 $1.29B $-0.16B -12.37%
2023-12-31 $1.26B $-0.21B -16.90%
2023-09-30 $-0.53B $-0.23B 42.59%
2023-06-30 $0.02B $-0.26B -1450.00%
2023-03-31 $0.55B $-0.34B -61.65%
2022-12-31 $1.10B $-0.34B -30.81%
2022-09-30 $3.01B $-0.44B -14.65%
2022-06-30 $2.58B $-0.40B -15.54%
2022-03-31 $2.15B $-0.62B -28.67%
2021-12-31 $1.47B $-0.59B -39.97%
2021-09-30 $1.21B $-0.53B -43.73%
2021-06-30 $0.95B $-0.48B -50.58%
2021-03-31 $0.71B $-0.16B -22.07%
2020-12-31 $0.67B $-0.14B -20.21%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.691B $1.371B
Clover Health Investments Corp. is a healthcare technology company. It uses its proprietary technology platform to collect, structure and analyze health and behavioral data to improve medical outcomes and lower costs for patients. Clover Health Investments Corp., formerly known as Social Capital Hedosophia Holdings Corp. III, is based in Calif.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $39.096B 54.00
Hims & Hers Health (HIMS) United States $13.681B 142.14
Tempus AI (TEM) United States $11.156B 0.00
Inspire Medical Systems (INSP) United States $4.596B 71.81
IRhythm Technologies (IRTC) United States $4.484B 0.00
Privia Health (PRVA) United States $2.963B 202.50
Enovis (ENOV) United States $2.069B 11.53
Schrodinger (SDGR) United States $1.747B 0.00
Phreesia (PHR) United States $1.537B 0.00
Omnicell (OMCL) United States $1.346B 23.74
Azenta (AZTA) United States $1.233B 57.32
10x Genomics (TXG) United States $1.115B 0.00
Fulgent Genetics (FLGT) United States $0.599B 0.00
Butterfly Network (BFLY) United States $0.571B 0.00
Talkspace (TALK) United States $0.517B 154.50
Veradigm (MDRX) United States $0.455B 0.00
Claritev (CTEV) United States $0.435B 0.00
Standard BioTools (LAB) United States $0.406B 0.00
TruBridge (TBRG) United States $0.372B 825.00
Health Catalyst (HCAT) United States $0.291B 0.00
Nyxoah SA (NYXH) Belgium $0.206B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.205B 0.00
EUDA Health Holdings (EUDA) Singapore $0.146B 0.00
Pulmonx (LUNG) United States $0.131B 0.00
American Well (AMWL) United States $0.111B 0.00
CareCloud (CCLD) United States $0.086B 3.27
MDxHealth SA (MDXH) Belgium $0.084B 0.00
Retrieve Medical Holdings (RMHI) United States $0.083B 0.00
Outset Medical (OM) United States $0.067B 0.00
111 (YI) China $0.065B 0.00
P3 Health Partners (PIII) United States $0.059B 0.00
HeartBeam (BEAT) United States $0.054B 0.00
Zepp Health (ZEPP) Netherlands $0.041B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.023B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
MSP Recovery (MSPR) United States $0.015B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Streamline Health Solutions (STRM) United States $0.011B 0.00
Precipio (PRPO) United States $0.011B 0.00
Healthcare Triangle (HCTI) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Movano (MOVE) United States $0.007B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00